Evidence gradeAApproved drug or multiple human RCTs
Human studies4000published, approximate count
Half-lifeAbout 3 hourstime for levels to halve
Route studiedSubcutaneous injectionGrowth factor
Watching Somatropin (human growth hormone)?
When Somatropin (human growth hormone)'s status or evidence changes, it's in the next morning's email.
What it is
Somatropin is recombinant human growth hormone: a 191-amino-acid protein identical to the hormone the pituitary makes. It raises IGF-1, which drives growth in children and, in adults, shifts the body toward more lean tissue and less fat. Many brands sell the same molecule as daily injections, including Genotropin, Humatrope, Norditropin, Omnitrope and Zomacton. Three weekly products work differently: Skytrofa (lonapegsomatropin, 2021) is somatropin on a carrier that releases it slowly, while Sogroya (somapacitan, 2020) and Ngenla (somatrogon, 2023) are modified growth hormones that stay in the blood longer.
Approved uses are specific: children with growth failure from growth hormone deficiency, Turner, Prader-Willi or Noonan syndrome, small size at birth, or idiopathic short stature, plus adults with proven growth hormone deficiency, and HIV wasting (Serostim). In adults with real deficiency, trials show more lean mass, less fat and a smaller waist. In healthy older people it is a different story. A review of 18 trials with 220 people on growth hormone found 2.1 kg more lean mass and 2.1 kg less fat, no change in weight or bone density, and more swelling, joint pain, carpal tunnel syndrome and diabetes.
Read the full overview 1 more
US law treats growth hormone unlike most drugs. Under 21 U.S.C. 333(e), knowingly distributing it, or possessing it to distribute, for any use other than an FDA-approved one on a doctor's order is a felony punishable by up to 5 years in prison, or 10 if the offense involves someone under 18. That makes supplying it for anti-aging, bodybuilding or sports illegal, even with a prescription, because those uses are not FDA-authorized. Somatropin is also banned in sport at all times, and since March 2020 FDA regulates it as a biologic that compounding pharmacies cannot make.
Structure191 amino acids, full sequence not drawn
Length
191 amino acids
Molecular weight
22,124 Da (Genotropin label)
Origin
Recombinant protein with a sequence identical to pituitary growth hormone; Genotropin is made in E. coli. From 1963 to 1985, US patients received growth hormone extracted from human cadaver pituitaries.
How Somatropin (human growth hormone) works
What it binds to, and what happens inside the body after that, step by step.
TargetGrowth hormone receptor (agonist); acts largely through IGF-1
Somatropin binds growth hormone receptors in the liver, fat, muscle and bone. The liver responds by making IGF-1, which carries most of the growth signal to growth plates. Growth hormone itself breaks down fat, builds protein and works against insulin, which is why it can raise blood sugar. It also makes the body hold sodium and water, the source of the swelling and joint pain that are its most common side effects.
1Injection under the skinDaily for most brands; weekly for Skytrofa, Sogroya and Ngenla. About 80% of a Genotropin dose reaches the blood.
2GH receptor activationBinds growth hormone receptors in liver, fat and muscle.
3IGF-1 risesThe liver makes more IGF-1; doctors adjust adult doses to keep IGF-1 in the normal range.
4Body composition shiftsFat breakdown rises and protein building increases; in healthy older adults, lean mass rose 2.1 kg and fat fell 2.1 kg.
5Linear growth in childrenIGF-1 drives growth plate activity until the plates close; treatment for height stops when they fuse.
What the studies show
Human results and animal results are kept apart below. A result in rats tells you a mechanism is plausible. It does not tell you what happens in a person.
AEvidence
Decades of RCTs support somatropin for childhood growth disorders and adult growth hormone deficiency, where it improves body composition and, per the Endocrine Society, exercise capacity, bone and quality of life. In healthy older adults and athletes, systematic reviews find about 2 kg more lean mass and 2 kg less fat, but no clear gain in strength or endurance, and more side effects including diabetes. Weekly analogs matched or beat daily somatropin in phase 3 trials.
How far the evidence reachesHighest rung: Regulatory approval
Cell studiesIn a dish None listed
Animal studiesRodents and other models None listed
Small human studiesOpen-label, case series 2 key studies below
No preclinical studies are listed as key studies here. The human data above carries the evidence.
New studies
When a new Somatropin (human growth hormone) study in people is published, the daily email covers it.
What nobody has measured yet
These are questions the published research has not answered.
01Long-term effects of years of use in healthy older adults, including cancer and heart disease: never tested in a long trial
02Whether GH improves strength or performance in trained athletes at the doses used covertly
03Long-term safety of the weekly analogs beyond their trial periods
04Identity, dose and sterility of GH bought online as a research chemical
Somatropin (human growth hormone) from discovery to today
1963US children begin receiving growth hormone extracted from cadaver pituitaries (treated 1963 to 1985).
1985Pituitary-derived growth hormone treatment in the US ends. Recipients later develop Creutzfeldt-Jakob disease: 26 cases in the US cohort by 2004.
1987Humatrope, a recombinant somatropin, is approved in the US.
1990Rudman's NEJM study: 12 men over 60 given GH for 6 months gain 8.8% lean mass and lose 14.4% fat.
2006Omnitrope becomes the first biosimilar authorized in the EU.
2007Systematic review of 220 healthy older adults concludes GH cannot be recommended as an anti-aging therapy and notes that distributing it for that use is illegal in the US.
2020Somatropin products become biologics licenses on March 23; FDA approves weekly Sogroya for adults (August 28).
2025Weekly Skytrofa approved for adults with growth hormone deficiency (July); weekly options now cover adults and children.
Approval or regulatory milestoneResearch milestone
Legal and regulatory status
FDA-approved An FDA-approved prescription product exists for this molecule.
Approved products
Humatrope (Eli Lilly)Growth hormone deficiency, Turner syndrome, idiopathic short stature, SHOX deficiency, small for gestational age; adult growth hormone deficiencyUS, 1987
Genotropin (Pfizer)Growth hormone deficiency, Prader-Willi syndrome, small for gestational age, Turner syndrome, idiopathic short stature; adult growth hormone deficiencyUS, 1995
Omnitrope (Sandoz)Follow-on somatropin; the first biosimilar authorized in the EU (April 2006)US and EU, 2006
Sogroya (somapacitan, Novo Nordisk)Weekly; adults with growth hormone deficiency (2020), children 2.5 and older (2023), extended to SGA, Noonan syndrome and idiopathic short stature (2026)US, 2020
Skytrofa (lonapegsomatropin, Ascendis)Weekly prodrug; children 1 and older with growth hormone deficiency (2021), adults with growth hormone deficiency (2025)US, 2021
Ngenla (somatrogon, Pfizer)Weekly; children 3 and older with growth hormone deficiencyUS, 2023
21 U.S.C. 333(e) makes it a crime to knowingly distribute, or possess with intent to distribute, human growth hormone for any use in humans other than treatment of a disease or recognized medical condition authorized by HHS under section 355 and ordered by a physician: up to 5 years in prison, or 10 years if the offense involves someone under 18. The statute defines human growth hormone as somatrem, somatropin or an analogue of either, and the DEA is authorized to investigate. This is stricter than the general rule that doctors may prescribe approved drugs off label. FDA's 2020 list of drugs deemed biologics also names Norditropin, Zomacton, Serostim (HIV wasting with cachexia), Nutropin, Nutropin AQ, Saizen, Zorbtive and Accretropin; not all of these are still marketed. The weekly products have different molecules (a PEG-linked prodrug, an albumin-binding analog and an hCG-CTP fusion protein) and different doses; they are not interchangeable mg for mg with daily somatropin. Prohibited at all times under WADA S2.2.3, which names growth hormone and the analogues lonapegsomatropin, somapacitan and somatrogon.
Sport (WADA)
Prohibited. Tested athletes can fail a drug test for it.
Compounding pharmacies
Not compoundable. Somatropin products were approved as drugs (NDAs) and on March 23, 2020 were deemed biologics licenses. From that date they are not eligible for the 503A or 503B compounding exemptions, so a compounding pharmacy cannot legally make somatropin. Growth hormone sold online as a research chemical is not an approved product, and selling it for non-approved uses falls under 21 U.S.C. 333(e).
When the FDA or WADA changes Somatropin (human growth hormone)'s status, it's in the next morning's email.
How long it stays in the body
Half-life
About 3 hours
About 3 hours after subcutaneous injection in adults with GH deficiency; about 0.4 hours given intravenously (Genotropin label)
Routes studied
Subcutaneous injection
Bioavailability
About 80% after subcutaneous injection (Genotropin label)
Notes
The longer half-life under the skin reflects slow absorption from the injection site. Peak level about 6 hours after a subcutaneous dose in adults. Broken down like other proteins in the liver and kidneys. Weekly products are built to last longer: Skytrofa releases somatropin from a PEG carrier (the whole conjugate is 63 kDa), Sogroya binds albumin, and Ngenla carries extra hCG-derived peptide segments. Not studied in kidney or liver impairment (Genotropin label).
Single-dose clearance
How much of Somatropin (human growth hormone) is left after a single dose
50%left after 3 hours
Half-lifeAbout 3 hours
About 97% cleared15 hours
Simple first-order model from the published half-life. Real clearance varies with dose, route, kidney and liver function and formulation. This is not a dosing schedule.
Doses used in published studies
This table records the doses that trials and approved labels used, with the source for each row. It is a record of research, not a recommendation, and it is open to free members.
Doses used in published research and approved labels6 rows
Study or labelDoseRouteFrequencyDurationSource
Checking membershipEach row names the trial or label, the dose, route, frequency, duration and a link to the source. Free account, no card.
Swelling of hands and feetPeripheral swelling 17.5% vs 5.1% on placebo in adults with GH deficiency over 6 months (Genotropin label); usually early and dose-related.Common
Joint pain and stiffnessArthralgia 17.3% vs 4.2%; pain in extremities 14.7% vs 5.9%.Common
Tingling, numbness and carpal tunnel syndromeParesthesia 9.6% vs 1.9% in adults; carpal tunnel symptoms in 32% of older men on GH plus testosterone vs 0% on placebo.Common
Injection site reactions and lipoatrophyPain, rash, nodules or fat loss at injection sites; rotate sites.Common
High blood sugar or new diabetesThe label says GH can unmask glucose intolerance. In healthy older adults, 18 GH-treated men vs 7 without GH developed diabetes or glucose intolerance.Uncommon
Raised pressure inside the skullHeadache, vision changes, nausea; usually reverses when the dose is lowered or stopped.Rare
Death in critically ill patientsIn 2 trials of 522 ICU patients without GH deficiency, mortality was 42% on high-dose GH vs 19% on placebo (label).Rare
Second tumors in childhood cancer survivorsHigher risk of a second neoplasm, especially meningioma after head radiation (label).Rare
Slipped capital femoral epiphysis, worsening scoliosis, pancreatitisLabel warnings, mainly in children.Rare
Groups with specific risks
Acute critical illness after open heart or abdominal surgery, multiple trauma, or acute respiratory failure
Children with Prader-Willi syndrome who are severely obese, have severe breathing problems, or a history of upper airway obstruction or sleep apnea (sudden deaths reported)
Active cancer
Active proliferative or severe non-proliferative diabetic retinopathy
Known hypersensitivity to somatropin or excipients
Growth promotion in children with closed growth plates
Interactions
Glucocorticoids: GH lowers cortisol activation (11-beta-HSD-1 inhibition) and can unmask adrenal insufficiency; people on replacement may need higher doses. High steroid doses can blunt growth in children (label).
Drugs cleared by CYP450 enzymes: GH may speed their clearance; monitor (label).
Oral estrogen: women may need larger GH doses (label).
Insulin and other diabetes drugs: doses may need adjustment because GH raises blood sugar (label).
Thyroid: hypothyroidism may appear or worsen; check thyroid function (label).
What people say online, checked against the studies
Tap a claim to see what the studies found.
The claim"HGH reverses aging."Not supportedThe evidence does not back this
In 220 healthy older adults across 18 trials, GH changed body composition by about 2 kg each way but did not change weight or bone density, and raised rates of swelling, joint pain, carpal tunnel and diabetes. The authors concluded it cannot be recommended as an anti-aging therapy.
The claim"HGH makes you stronger and fitter."MixedSome studies agree, some do not
A review of 303 young athletes found more lean mass but no gain in strength or exercise capacity. One 96-person trial found a 3.9% rise in sprint capacity that disappeared 6 weeks after stopping.
The claim"A doctor can legally prescribe HGH for anti-aging or bodybuilding."Not supportedThe evidence does not back this
21 U.S.C. 333(e) makes distributing GH for any use other than an FDA-authorized one a felony. Ordinary off-label prescribing rules do not apply to growth hormone.
The claim"Weekly growth hormone shots are the same drug as daily somatropin."MixedSome studies agree, some do not
Skytrofa releases ordinary somatropin from a carrier. Sogroya and Ngenla are modified growth hormone molecules. All three have their own doses and are not swapped mg for mg.
The claim"HGH sprays and pills raise growth hormone."UntestedNobody has measured this in people
Somatropin is a 22 kDa protein, and every FDA-approved somatropin product is an injection. We found no published trial showing that an oral or spray product sold as HGH raises growth hormone in the blood.
Combinations people discuss
These pairings come up often. Almost none have been tested together in a trial, and the evidence note on each says so plainly.
Common among athletes and in anti-aging clinics to combine two body-composition signals.
EvidenceTested in two RCTs. In older men, the pair added 4.3 kg lean mass and marginal strength but caused carpal tunnel symptoms in 32%. In athletes, it raised sprint capacity 8.3%. Both are banned in sport, and GH distribution for this use is illegal in the US.
Discussed online to add the body's own GH pulses on top of injected GH.
EvidenceNever studied together. Stacking raises IGF-1 exposure with unknown safety.
Storage and stability
Dry powder (lyophilized)
Genotropin powder cartridges: refrigerate at 2 to 8 C until expiry, protect from light, do not freeze. Some single-dose devices may be kept up to 3 months at or below 25 C before mixing (label). Storage differs by brand.
Mixed with water (reconstituted)
Genotropin 5 mg and 12 mg cartridges: refrigerate at 2 to 8 C between uses and discard after 28 days; do not shake (label).
New Somatropin (human growth hormone) research, explained when it is published
One email when a trial reads out, a label changes or the FDA acts on a peptide. Free, every source linked, unsubscribe any time.
Frequently asked questions
What is somatropin used for?
Growth failure in children (growth hormone deficiency, Turner, Prader-Willi and Noonan syndromes, small for gestational age, idiopathic short stature), adults with proven growth hormone deficiency, and HIV wasting (Serostim).
Is HGH legal for anti-aging?
No. Under 21 U.S.C. 333(e), distributing growth hormone for any use other than an FDA-approved one on a doctor's order is a felony, with up to 5 years in prison. Anti-aging, bodybuilding and sports use are not approved uses.
Does HGH build muscle?
It adds lean mass, about 2 kg in reviews of older adults and athletes, but strength did not reliably improve, and in one trial the lean mass gain came mostly from extra body water. In a 96-person trial, only sprint capacity rose, by 3.9%.
What are the weekly growth hormone shots?
Sogroya (somapacitan, 2020), Skytrofa (lonapegsomatropin, 2021) and Ngenla (somatrogon, 2023). All are once a week. Sogroya and Skytrofa are approved for children and adults; Ngenla for children 3 and older.
What are the side effects of HGH?
Swelling, joint pain, tingling and carpal tunnel syndrome are the most common, especially in adults. It can raise blood sugar and unmask diabetes. Rare problems include raised pressure in the skull and, in children, hip and spine problems.
Can a compounding pharmacy make HGH?
No. Since March 23, 2020, somatropin has been regulated as a biologic, and biologics are not eligible for the compounding exemptions.